
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>News &amp; Press</title>
<link>https://gada.site-ym.com/news/default.asp</link>
<description><![CDATA[  Read about recent events, essential information and the latest community news.  ]]></description>
<lastBuildDate>Fri, 5 Jun 2026 11:20:28 GMT</lastBuildDate>
<pubDate>Thu, 30 Mar 2023 04:00:00 GMT</pubDate>
<copyright>Copyright &#xA9; 2023 Generic Animal Drug Alliance</copyright>
<atom:link href="https://gada.site-ym.com/news/news_rss.asp?cat=17621" rel="self" type="application/rss+xml"></atom:link>
<item>
<title>GADA in Support of Animal Drug User Fee Reauthorization</title>
<link>https://gada.site-ym.com/news/news.asp?id=639408</link>
<guid>https://gada.site-ym.com/news/news.asp?id=639408</guid>
<description><![CDATA[<span style="font-family: Arial;"><span style="font-size: 14px; background-color: #ffffff; font-family: Arial; color: #333333;"><strong>March 30, 2023</strong><br /></span><br style="box-sizing: border-box; color: #333333; font-size: 14px; background-color: #ffffff;" /><span style="font-size: 14px; background-color: #ffffff; color: #333333;">GADA Chair, Stephanie Batliner testified in support of animal drug user fee reauthorization legislation before the Energy and Commerce Committee’s Health Subcommittee on March 30, 2023. Seated behind and to the right is Ben Moses, GADA Vice Chair. The legislation is critical to support efficient and predictable pathways to market for new and innovative animal drugs and generic animal drugs. GADA represents the generic animal drug industry in negotiations with the FDA Center for Veterinary Medicine.</span></span>]]></description>
<pubDate>Thu, 30 Mar 2023 05:00:00 GMT</pubDate>
</item>
<item>
<title>Generic Animal Drug Advancement Act Introduced</title>
<link>https://gada.site-ym.com/news/news.asp?id=639409</link>
<guid>https://gada.site-ym.com/news/news.asp?id=639409</guid>
<description><![CDATA[<span style="font-family: Arial;"><span style="font-size: 14px; background-color: #ffffff; color: #333333;">The Generic Animal Drug Advancement Act, H.R. 1683, will update the Federal FD&amp;C Act to correct current limitations to the approval of generic animal drug applications. “The Generic Animal Drug Advancement Act cuts bureaucratic red tape and ensures safe, effective, and affordable generic animal drugs are readily available. This will help farmers ranchers keep their livestock healthy and allow pet owners the best ability to take care of their pets. I'm so grateful to have such great partners in GADA and its members," said Rep. Mace. <a href="https://www.gadaonline.org/newsevents/gada_act_introduction_press_release.pdf?pass=16" target="_blank"><strong>MORE</strong></a></span></span>]]></description>
<pubDate>Tue, 21 Mar 2023 05:00:00 GMT</pubDate>
</item>
<item>
<title>GADA Joins AHI in Urging Compounding Enforcement</title>
<link>https://gada.site-ym.com/news/news.asp?id=639416</link>
<guid>https://gada.site-ym.com/news/news.asp?id=639416</guid>
<description><![CDATA[<span style="color: #333333; font-family: Arial; font-size: 14px; background-color: #ffffff;">GADA has joined the Animal Health Institute (AHI) in a letter to CVM Director Tracey Forfa urging enforcement action now against compounding pharmacies’ copying approved medicines through bulk compounding practices. GFI #256 was published in October 2022, followed by announcement of delayed enforcement until April 2023. The letter to Director Forfa states that this grace period, granted to allow stakeholders time to amend their practices to comply with the Guidance, is being abused: some compounding pharmacists are pushing efforts to copy approved animal medicines.</span>]]></description>
<pubDate>Wed, 22 Feb 2023 15:36:00 GMT</pubDate>
</item>
</channel>
</rss>
